Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: Relationship to hypertension

Molecular Genetics and Metabolism

Volumn 63, Issue 3, 1998, Pages 214-223

  Iannello, Silvia ^a   Campione, Rosa ^a   Belfiore, Francesco ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Abdominal obesity; Hyperglucagonemia; Hyperinsulinemia; Hypertension; Increased NEFA; NIDDM; OGTT; Reduced lactate response

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); FATTY ACID; GLUCAGON; GLUCOSE; INSULIN; LACTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTATE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0031665984     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1997.2670     Document Type: Article

References (79)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1996.
2. Modan M, Halkin H, Almog S, Lusky A, Eshkil M, Shitrit A, Fuchs A. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985.
3. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 24:465-468, 1992.
4. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: Influence of body fat distribution. J Clin Endocrinol Metab 67:760-767, 1988.
5. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996.
6. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991.
7. Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520, 1989.
8. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987.
9. Shen DC, Shieh SM, Fuh MMT, Wu DA, Chen YDI, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66:580-583, 1988.
10. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus C. Racial differences and relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991.
11. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans. Diabetes Care 18:174-181, 1995.
12. Beatty OL, Harper R, Sheridan R, Brew-Atkinson A, Bell PM. Insulin resistance in offspring of hypertensive parents. Br Med J 307:92-95, 1993.
13. Christlieb AR, Krolewski AS, Warram JH, Soeldner JS. Is insulin the link between hypertension and obesity? Hypertension 7(Suppl. II):54-58, 1985.
14. Kelleher C, Kingston SM, Barry DG, Cole MM, Ferriss JB, Grealy G, Joyce C, O'Sullivan DJO. Hypertension in diabetic clinic patients and their siblings. Diabetologia 31:76-81, 1988.
15. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1:1336-1337, 1966.
16. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure in obesity. Hypertension 7:702-706, 1985.
17. Mahler RJ. Diabetes and hypertension. Horm Metab Res 22:599-607, 1990.
18. Weinsier RL, Norris DJ, Birch R, Bernstein RS, Pi-Sunyer FX, Yang M-U, Wang J, Pierson RN, Van Itallie TB. Serum insulin and blood pressure in an obese population. Int J Obes 10:11-17, 1986.
19. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Butturini U. The relationship between blood pressure and plasma insulin in non-obese and obese-diabetic subjects. Diabetologia 30:719-723, 1987.
20. O'Hare JA. The enigma of insulin resistance and hypertension. Insulin resistance, blood pressure and the circulation. Am J Med 84:505-510, 1988.
21. Johnson D, Prud'homme D, Despres JP, Nadeau A, Tremblay A, Bouchard C. Relation of abdominal obesity to hyperinsulinemia and high blood pressure in men. Int J Obes 16:881-890, 1992.
22. Krotkiewski M, Mandroukas K, Sjostrom L, Sullivan L, Wetterqvist H, Bjorntorp P. Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 28:650-658, 1979.
23. Singh RB, Rastogi SS, Singh DS, Mehta PJ. Effect of obesity and weight reduction in hypertension. Acta Cardiol 45:45-56, 1990.
24. Tedde R, Sechi LA, Marigliano A, Pala A, Scano L. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertension 2:163-170, 1989.
25. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 229:181-187, 1991.
26. Sims EA, Berchtold P. Obesity and hypertension: Mechanisms and implications for management. JAMA 247:49-52, 1982.
27. Izzo JL, Swislocki ALM. Workshop III-Insulin resistance: Is it truly the link? Am J Med 90(Suppl. 2):26-31, 1991.
28. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension. Diabetes 42:764-772, 1993.
29. Reaven GM, Chang H, Hoffmann BB, Azhar S. Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 38:1155-1160, 1989.
30. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512-516, 1987.
31. Bray GA, York DA. Genetically transmitted obesity in rodents. Physiol Rev 51:598-646, 1971.
32. Lillioja S, Foley J, Bogardus C, Mott D, Howard BV. Free fatty acid metabolism and obesity in man: in vivo and in vitro comparison. Metabolism 35:505-514, 1986.
33. Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F, Giorico MA, Ferrannini E. Acute elevation of free acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36:502-506, 1987.
34. Jensen MD, Raymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173, 1989.
35. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 748:399-406, 1995.
36. Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston DG, Elkeles RS. Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med 229:267-273, 1991.
37. Felber JP, Haesler E, Jequier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:1221-1229, 1993.
38. Pedersen SB, Borglum JD, Schmitz O, Bak JF, Sorensen NS, Richelsen B. Abdominal obesity is associated with insulin resistance and reduced glycogen synthetase activity in skeletal muscle. Metabolism 42:998-1005, 1993.
39. Boden G. Fatty acids and insulin resistance. Diabetes Care 19:394-395, 1996.
40. Ligtenberg JJ, van Tol A, van Haeften TW, Sluiter WJ, Reitsma WD, Dullaart RP. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycemia-induced hyperinsulinemia and alterations in high density lipoproteins in essential hypertension. J Intern Med 240:233-242, 1996.
41. Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol 17:64-71, 1997.
42. Wu MS, Jeng CY, Hollenbeck CB, Chen YD, Yaspan J, Reaven GM. Dose glucagon increase plasma NEFA concentration in humans with normal glucose tolerance. J Clin Endocrinol Metab 70:410-416, 1990.
43. Carlson MG, Snead WL, Campbell PJ. Regulation of free fatty acid metabolism by glucagon. J Clin Endocrinol Metab 77:11-15, 1993.
44. Lovejoy J, Newby FD, Gebhart SSP, DiGirolamo M. Insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin. Metabolism, 41:22-27, 1992.
45. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979.
46. Lovejoy J, Mellen B, DiGirolamo M. Lactate generation following glucose ingestion: Relation to obesity, carbohydrate tolerance and insulin sensitivity. Int J Obes 14:843-855, 1990.
47. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-DI. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988.
48. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 14:229-235, 1996.
49. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB. Documentation of hyperglucagonemia throughout the day in nonobese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:106-110, 1987.
50. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213-1217, 1995.
51. Voors AW, Radhakrishnamurthy B, Srinivasan SR, Webber LS, Berenson GS. Plasma glucose level related to blood pressure in 272 children, ages 7-15 years, sampled from a total biracial population. Am J Epidemiol 13:347-356, 1981.
52. Reaven PD, Barrett Connor EL, Browner DK. Abnormal glucose tolerance and hypertension. Diabetes Care 13:119-125, 1990.
53. Ferrannini E, Haffner SM, Stern MP, Mitchell BD, Natali A, Hazuda HP, Patterson JK. High blood pressure and insulin resistance: Influence of ethnic background. Eur J Clin Invest 21:280-287, 1991.
54. Cambien F, Warnet JM, Eschwege E, Jaqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose and lipids: Does plasma insulin explain their relationship? Arteriosclerosis 7:197-202, 1987.
55. Folsom AR, Burke GL, Byers CL, Hutchinson RG, Heiss G, Flack JM. Implications of obesity for cardiovascular disease in blaks: The CARDIA and ARIC Studies. Am J Clin Nutr 53(Suppl. 6): 1604S-1611S, 1991.
56. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP. The relationship between serum insulin levels and 8-year changes in lipid lipoprotein and blood pressure. Am J Epidemiol 136:12-22, 1992.
57. Zavaroni I, Mazza S, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Passeri M, Reaven GM. High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance. Diabetic Med 7:494-498, 1990.
58. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension 25:774-778, 1995.
59. +-Pump. B. Cellular Aspects (Skou JC, Norby JG, Maunsbach AB, Esmann M, Eds.). New York: A. R. Liss, 1988, pp 443-448.
60. Egan BM, Hennes MM, Stepniakowski KT, O'Shaughnessy IM, Kissebah AH, Goodfriend TL. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension 27:723-728, 1996.
61. Hennes MM, O'Shaughnessy IM, Kelly TM, La Belle P, Egan BM, Kissebah AH. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 28:120-126, 1996.
62. Grekin RJ, Vollmer AP, Sider RS. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 26:193-198, 1995.
63. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26:764-770, 1995.
64. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM. Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res 79:611-618, 1996.
65. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B. Linoleic acid and TNF-alpha cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 37:123-135, 1996.
66. +-Pump. B. Cellular Aspects (Skou JC, Norby JG, Maunsbach AB, Esmann M, Eds.). New York: A. R. Liss, 1988, pp 401-407.
67. Kelly RA, O'Hara DS, Mitch WE, Smith TW. Identification of Na,K-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids. J Biol Chem 261:11704-11711, 1986.
68. Belfiore F, Iannello S, Rabuazzo AM, Borzi V. The activity of sodium and potassium activated adenosine-triphosphatase (Na,K-ATPase) in the adipose tissue of obese patients. In Obesity: Pathogenesis and Treatment (Enzi G, Crepaldi G, Pozza G, Renold AE, Eds.). New York and London: Academic Press, 1981, pp 129-137.
69. De Luise M, Blackburn GL, Flier JS. Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med 303:1017-1022, 1980.
70. Iannello S, Campione R, Volpicelli G, Prestipino M, Belfiore F. Na,K-Adenosine triphosphatase in mouse and human obesity and diabetes, as related to insulin, NEFA and hypertension. Diabetologia 37(Suppl. 1):A133, 1994.
71. + in normotensive obese women and obese women receiving medication for hypertension. Biochem Med 32:232-241, 1984.
72. Meehan WP, Darwin CH, Maalouf BB, Buchanan TA, Saad MF. Insulin and hypertension: are they related? Steroids 58:621-634, 1993.
73. O'Brien T, Young WF, Palumbo PJ, O'Brien PC, Service FJ. Is the hyperinsulinemia of insulinoma associated with hypertension and hypertriglyceridemia. Diabetologia 34(Suppl 2):A19, 1991.
74. Sawicki PT, Heinemann L, Starke A, Berger M. Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia 35:649-652, 1992.
75. Collins VR, Dowse GK, Finch CF, Zimmet P. An inconsistent relation between insulin and blood pressure in three Pacific island population. J Clin Epidemiol 43:1369-1378, 1990.
76. Bonner G. Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol 24(Suppl 2):S39-49, 1994.
77. O'Shaughnessy IM, Myers TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, Egan BM, Kissebah AH. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26:186-192, 1995.
78. Belfiore F, Iannello S, Rabuazzo AM, Campione R. Metabolic effects of short-term fasting in obese hyperglycaemic humans and mice. Int J Obesity 11:631-640, 1987.
79. Wolever TMS, Bentum-Williams A, Jenkins DJA. Physiological modulation of plasma free fatty acid concentrations by diet. Metabolic implications in nondiabetic subjects. Diabetes Care 18:962-970, 1995.